Press Release
“Enrichment of Genomic Loci for Targeted Sequencing Application” Is Focus of 2009 AGBT Conference Workshop
LEXINGTON, Massachusetts, USA – January 30, 2009 – Jeff Olson, Manager of Nucleic Acid Applications, of RainDance Technologies, Inc., will present “Enrichment of Genomic Loci for Targeted Sequencing Applications,” to explain application of the RainStorm micro-droplet technology on the new RDT 1000 instrument, at the 2009 Advances in Genome Biology and Technology (AGBT) conference on Friday, February 6th, in Marco Island, Florida.
RainDance Technologies is a provider of innovative microdroplet-based solutions which enable and benefit biological applications utilized in human health and disease research.
“Recent advances in DNA sequencing technologies have improved accuracy and dramatically reduced cost. However, even with the improved efficiency of “second generation” systems, sequencing thousands of human genomes across various phenotypes is still economically unrealistic. To exploit the full potential of new sequencing techniques, a robust method for isolating biologically relevant genomic loci on the megabase scale will be required,” said Olson.
Olson has more than twenty years of experience in molecular biology, technology development and DNA diagnostics. He manages the Nucleic Acids Applications group at RainDance Technologies (www.RainDancetech.com) and is responsible for the development of the company’s Sequence Enrichment application.
Olson will present “Enrichment of Genomic Loci for Targeted Sequencing Applications” at the 2009 AGBT meeting on Friday, February 6th, at 2:00 p.m. in the Islands Ballroom at the Marco Island Marriott Resort, Golf Club & Spa, Florida.
The 2009 Advances in Genome Biology and Technology conference (http://www.agbt.org/), a premier scientific forum for capturing the latest advances in new DNA sequencing technologies and for presentations on the applications of genomics to diverse areas in biology and biomedicine, runs February 4-7, 2009.
About RainDance Technologies, Inc.
RainDance's proprietary technology platform delivers exquisite sensitivity and data quality that inspires scientists, researchers and clinicians to rethink the way they design experiments, approach discovery, or conduct clinical diagnostics. The core RainStorm™ technology empowers customers to conduct de novo science in an ultra-high throughput, simple, flexible, and low-cost manner. RainDance's commercial products include instruments and high-value consumables and reagents for sequence enrichment for next-generation sequencing, ultra-deep sequencing, and methylation analysis. RainDance sells directly in the U.S. and in Europe, and is building distribution networks in Europe and Asia-Pacific. RainDance Technologies has approximately 70 employees worldwide. For more information, please visit www.raindancetech.com.
RainStorm is a trademark of RainDance Technologies, Inc.
For corporate questions contact:
Chris McNary
RainDance Technologies
44 Hartwell Avenue
Lexington, MA 02421
Phone — 781-861-6300
mcnaryc@raindancetech.com
For technical questions contact:
James Brayer
RainDance Technologies
44 Hartwell Avenue
Lexington, MA 02421
Phone — 781-861-6300
info@raindancetech.com
For press inquiries:
Colin Sanford
Phone — 203-340-2441
colin@bioscribe.com
